What is SANUWAVE Health, Inc.'s revenue?

SANUWAVE Health, Inc. (SNWV) generated $44.3M in revenue over the trailing twelve months, up 22.5% year over year.

Is SANUWAVE Health, Inc. profitable?

SANUWAVE Health, Inc. reported $16.5M in net income over the trailing twelve months, a 37.2% net margin.

What are SANUWAVE Health, Inc.'s profit margins?

Gross margin is 76.7% and operating margin is 7.3%, with a 37.2% net margin.

What is SANUWAVE Health, Inc.'s earnings per share?

SANUWAVE Health, Inc.'s diluted EPS over the trailing twelve months is $0.38.

Where does SANUWAVE Health, Inc.'s income statement data come from?

Every line is extracted from SANUWAVE Health, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

SANUWAVE Health, Inc. SNWV Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	$9.62M+3.1%	$13.39M+29.7%	$11.27M+20.4%	$10.05M+40.4%	$9.33M+61.3%
Total cost of revenue	$2.19M+11.7%	$3.39M+48.4%	$2.53M+10.2%	$2.21M+14.8%	$1.96M+23.6%
Gross profit	$7.43M+0.8%	$10M+24.4%	$8.74M+23.7%	$7.85M+49.8%	$7.38M+75.5%
Gross margin	77.3%-1.8pp	74.7%-3.2pp	77.6%+2.1pp	78.1%+4.9pp	79%+6.4pp
Research and development	$660K+217%	$606K+294%	$345K+114%	$194K-0.5%	$208K+27.6%
Selling and marketing	$2.4M+56.7%	$2.13M+15.0%	$2.08M-5.5%	$1.67M+61.9%	$1.53M+24.3%
General and administrative	$5.25M+8.4%	$4.97M+30.8%	$5.19M+72.2%	$4.37M+100%	$4.84M+23.6%
Compensation and benefits	$1.61M+65.2%	$1.34M-11.7%	$1.41M—	$1.13M—	$975K—
Occupancy and equipment	$46K+119%	$37K—	$37K—	$37K—	$21K—
Depreciation and amortization	$294K+40.7%	$340K+56.0%	$222K+7.8%	$174K-3.3%	$209K+53.7%
Provision for credit losses	$40K+21.2%	$90K+47.5%	$0—	$98K—	$33K-77.6%
Goodwill impairment	——	$0—	$0—	$0—	$0—
Other operating expenses	855,500,000%+178,100,000%	2,902,400,000%+832,200,000%	784,100,000%+225,700,000%	641,000,000%+281,700,000%	677,400,000%+127,800,000%
Total operating expenses	$8.56M+26.3%	$8M+32.7%	$7.84M+40.4%	$6.41M+78.4%	$6.77M+23.3%
Total costs & expenses	——	$147.5K+22.4%	$147.5K+22.4%	$147.5K+22.4%	$147.5K+22.4%
Operating income	-$1.12M-287%	$2M-0.4%	$903K-39.1%	$1.44M-12.7%	$601K+146%
Operating margin	-11.7%-18.1pp	15%-4.5pp	8%-7.8pp	14.3%-8.7pp	6.4%+28.8pp
Interest expense	$401K-64.1%	$453K-59.6%	$1.04M-8.6%	$1.14M+4.9%	$1.12M+15.1%
Other income (expense), net	-$315K+95.3%	$5.78M+138%	$8.79M+139%	-$887K-120%	-$6.72M-91.8%
Gain (loss) on disposal of assets	-$6K—	$375K—	——	——	$0—
Income before income taxes	——	$2.97M+136%	$2.97M+136%	$2.97M+136%	$2.97M+136%
Net income	-$1.44M+76.5%	$7.69M+158%	$9.69M+146%	$551K-91.1%	-$6.12M-27.5%
Net margin	-15%+50.6pp	57.4%+186pp	86%+312pp	5.5%-80.9pp	-65.6%+17.4pp
Diluted earnings per share	-$0.17+76.4%	$0.20+118%	$0.39+106%	-$0.04—	-$0.72—
Basic earnings per share	-$0.17+76.4%	$0.90+180%	$1.13+117%	$0.06+500%	-$0.72—
Weighted-average shares, diluted	8.6M+0.5%	9.1M+104%	9.1M+187%	9.2M+148%	8.5M+176%
Weighted-average shares, basic	8.6M+0.5%	8.6M+91.9%	8.6M+169%	8.6M+172%	8.5M+176%
Share-based compensation expense related to employee stock plans	$1.44M+30.7%	$1.34M+254%	$1.4M+269%	$1.13M+199%	$1.1M+191%
Pre-tax stock-based compensation cost	$1.47M+51.0%	$1.34M+253%	$1.4M+269%	$1.13M+199%	$975K+158%
Accounts Receivable, Allowance for Credit Loss, Recovery	——	$0-100%	$0-100%	$0-100%	$0-100%
Amortization Of Financing Costs And Discounts	$57K-89.2%	$45K-93.8%	$354K-76.7%	$532K-69.1%	$530K-65.9%
Amortization of right-of-use leases	$18K-72.3%	$41K-53.9%	$83K-54.1%	$120K+2,300%	$65K-20.7%
Stock options excluded as their inclusion would be anti-dilutive (in shares)	1.5M-7.3%	342K-77.7%	86K-98.1%	——	1.6M-64.8%
Capital investments accrued but not yet paid	$16K—	——	——	——	$0—
Software amortization expense	$0—	——	——	——	——
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation	-$1.18M+32.0%	$2.36M-66.2%	$1.11M+38.4%	-$5K—	-$1.74M-252%
Change In Fair Value Of Derivative Liabilities	$0-100%	-$5.92M-143%	-$6.1M-132%	-$990K+73.4%	$4.9M+96.0%
Issuances (in dollars per share)	——	——	——	——	——
Forfeited or expired (in dollars per share)	——	——	——	——	——
Exercised (in dollars per share)	——	——	——	——	——
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	-$1.44M+76.5%	$7.69M+158%	$9.69M+146%	$551K-91.1%	-$6.12M-30.5%
New service agreements	——	$192K+415%	$192K+415%	$192K+415%	$192K+415%
Revenue recognized that was included in deferred income at the beginning of the period	——	$43K+81.1%	$43K+81.1%	$43K+81.1%	$43K+81.1%
Capitalize interest into senior secured debt	$0-100%	$0-100%	$0-100%	-$202K-118%	$202K-82.4%
Conversion of warrants to common stock	——	$0-100%	$0-100%	$0-100%	$0-100%
Federal	——	$10K—	$10K—	$10K—	$10K—
Foreign	——	$0—	$0—	$0—	$0—
Current State And Local Tax Expense Benefit	——	$11.5K+70.4%	$11.5K+70.4%	$11.5K+70.4%	$11.5K+70.4%
Federal	——	$0—	$0—	$0—	$0—
Deferred Foreign Income Tax Expense Benefit	——	$0—	$0—	$0—	$0—
Deferred taxes	——	$0—	$0—	$0—	$0—
State	——	$0—	$0—	$0—	$0—
Deposits, Property, Plant, and Equipment	$66K—	——	——	——	$0—
Effect of exchange rate changes on cash, cash equivalents and restricted cash	$0—	$0—	$0—	$0-100%	$0-100%
Effective tax rates	——	$0—	$0—	$0—	$0—
Income taxes at U.S. statutory rate of 21%	——	21%—	——	——	——
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent	——	-91.5%—	——	——	——
Net operating losses limited under section 382	——	$2.32M—	$2.32M—	$2.32M—	$2.32M—
Net operating losses limited under section 382	——	77.9%—	——	——	——
Warrant revaluation	——	-14.3%—	——	——	——
Warrant revaluation	——	-$425.5K-235%	-$425.5K-235%	-$425.5K-235%	-$425.5K-235%
Other	——	$0—	$0—	$0—	$0—
Non-deductible gain on warrant adjustment valuation	——	——	——	——	——
Share-based compensation	——	6.9%—	——	——	——
State income taxes – net of federal income tax benefit	——	0.3%—	——	——	——
Finance Lease Principal Payments	$0-100%	——	——	$92K-17.1%	$57K+96.6%
Gain (Loss) on Disposition of Assets	-$6K—	——	——	——	$0—
Goodwill impairment losses	——	$0—	$0—	$0—	$0—
Income Loss From Continuing Operations Before Income Taxes Domestic	——	——	——	——	——
Income Loss From Continuing Operations Before Income Taxes Foreign	——	$0+100%	$0+100%	$0+100%	$0+100%
Federal taxes	——	$0—	$0—	$0—	$0—
Foreign	——	$0—	$0—	$0—	$0—
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount	——	-$2.72M-825%	-$2.72M-825%	-$2.72M-825%	-$2.72M-825%
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount	——	$624.75K+136%	$624.75K+136%	$624.75K+136%	$624.75K+136%
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount	——	$34.25K—	$34.25K—	$34.25K—	$34.25K—
Share-based compensation	——	$180.5K—	$180.5K—	$180.5K—	$180.5K—
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount	——	——	——	——	——
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount	——	$9K+260%	$9K+260%	$9K+260%	$9K+260%
Income Taxes Paid, Net	——	$6.75K+575%	$6.75K+575%	$6.75K+575%	$6.75K+575%
Accounts payable	$54K-87.2%	-$785K-91.9%	——	——	$423K+166%
Increase (Decrease) in Accounts Receivable	$617K+8.2%	$909K+64.7%	$737K+282%	$80K-83.7%	$570K+475%
Accrued liabilities	$205K+162%	$676K+778%	$1.09M+15.5%	$532K-26.4%	-$332K-233%
Increase (decrease) in contract liabilities and current deferred income	——	——	——	——	——
Increase (Decrease) in Inventories	$39K-97.0%	——	$903K+29.0%	$454K+68.1%	$1.31M+367%
Short- and long-term operating lease liabilities	$600K+220%	——	——	——	-$500K—
Increase (Decrease) in Prepaid Expense and Other Assets	-$78K-124%	——	——	$906K+1,124%	$325K+269%
Debt	$546K-71.4%	——	$1.8M-46.5%	$1.94M-43.4%	$1.91M-41.5%
Interest Paid, Excluding Capitalized Interest, Operating Activity	$401K-64.1%	$453K-59.6%	$1.04M-8.6%	$1.14M+4.9%	$1.12M+15.1%
Inventory Write Down	$69K—	——	——	——	$0—
Issuance Of Stock And Warrants For Services Or Claims	$97K—	——	——	——	$0—
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	-$1.42M-2,389%	-$1.24M-119%	-$4.45M-923%	$161K-41.2%	-$57K-236%
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	-$158K+2.5%	$279K+218%	$4.48M+9,423%	-$1.16M-1,160%	-$162K-42.1%
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	$397K+126%	$3.32M+348%	$1.08M-15.7%	$993K—	-$1.52M-238%
Number of operating segments	1+300%	0.3—	0.3—	0.3—	0.3—
Number of reportable segments	10.0%	——	——	——	1+300%
Occupancy and Related Charges	$46K+119%	$37K—	$37K—	$37K—	$21K—
Operating Lease Payments	$37K—	$77K+175%	——	——	$0—
Foreign currency translation gains (losses)	$0—	$0—	$0—	$0-100%	$0-100%
Other Nonoperating Expense	$60K+5,900%	$0—	$14K-86.8%	$27K-96.1%	$1K-99.0%
Other Nonoperating Income	$291K+216%	$457K+833%	$5.17M+86,067%	$89K+790%	$92K-96.7%
Other income, net (Note 6)	-$315K+95.3%	$5.78M+138%	$8.79M+139%	-$887K-120%	-$6.72M-91.8%
Payments for Software	$69K—	——	——	——	$0—
Payments Of Stock Issuance Costs	——	——	——	——	——
Payments to Acquire Property, Plant, and Equipment	$23K-85.8%	$96K-59.3%	$525K+994%	$1.16M+1,160%	$162K+42.1%
Proceeds from Issuance of Common Stock	——	$0-100%	$0-100%	$0-100%	$0-100%
Cash received from option exercises	$19K—	$197K—	$106K—	$253K—	$0—
Net additions (releases) charged to costs and expenses	$40K+21.2%	$90K+47.5%	$0—	$98K—	$33K-77.6%
Repayments of Secured Debt	$1.44M—	——	——	——	$0—
Stock-based compensation	$1.61M+65.2%	$1.34M-11.7%	$1.41M—	$1.13M—	$975K—
Weighted-average grant date fair value of stock options (in dollars per share)	$27.71+0.9%	$31.13+114%	——	——	$27.47—
Granted (in shares)	168K-4.5%	541K-51.7%	——	——	176K—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period	37K-53.8%	268K+972%	——	——	80K—
Stock options forfeited, aggregate intrinsic value	$0—	$0—	$0—	——	——
Stock options granted, aggregate intrinsic value	$0-100%	——	$21K-99.1%	$18K-99.2%	$1.39M-39.8%
Stock options exercised, aggregate intrinsic value	$4K—	$104K—	$165K—	——	——
Options canceled (in dollars per share)	$21.82—	$18.42—	——	——	——
Granted (in shares)	$27.71+1.1%	$31.07—	——	——	$27.42—
Exercised (in shares)	$14.20—	$14.67—	——	——	——
Shares granted in lieu of board of director fees	$103K—	——	——	$77K—	$0—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period	1K—	38K—	——	——	——
Shares granted in lieu of board of director fees	$103K—	——	——	——	——
Issuance of common stock in connection with the Spin-Off and reclassification of net parent investment	——	——	——	——	——
Stock Issued During Period, Value, Stock Options Exercised	$19K—	$180K—	$122K—	$253K—	$0—
Stock options granted in lieu of cash bonus	$69K-41.0%	——	——	——	$117K—
Interest expense and penalties, net (benefit)/charge recognized	——	$0—	$0—	$0—	$0—
Common shares (in shares)	8.6M+0.5%	——	——	——	8.5M+181%
EBIT	-$1.12M-287%	$2M-0.4%	$903K-39.1%	$1.44M-12.7%	$601K+146%
EBITDA	-$830K-202%	$2.34M+5.1%	$1.15M-30.8%	$1.62M-15.1%	$810K+170%
EBITDA	-$830K-202%	$2.34M+5.1%	$1.15M-30.8%	$1.62M-15.1%	$810K+170%
EBITDA margin	-8.6%-17.3pp	17.5%-4.1pp	10.2%-7.5pp	16.1%-10.5pp	8.7%+28.7pp
EBIT	-$1.12M-287%	$2M-0.4%	$903K-39.1%	$1.44M-12.7%	$601K+146%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about SANUWAVE Health, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is SANUWAVE Health, Inc.'s revenue?: SANUWAVE Health, Inc. (SNWV) generated $44.3M in revenue over the trailing twelve months, up 22.5% year over year.
Is SANUWAVE Health, Inc. profitable?: SANUWAVE Health, Inc. reported $16.5M in net income over the trailing twelve months, a 37.2% net margin.
What are SANUWAVE Health, Inc.'s profit margins?: Gross margin is 76.7% and operating margin is 7.3%, with a 37.2% net margin.
What is SANUWAVE Health, Inc.'s earnings per share?: SANUWAVE Health, Inc.'s diluted EPS over the trailing twelve months is $0.38.
Where does SANUWAVE Health, Inc.'s income statement data come from?: Every line is extracted from SANUWAVE Health, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.